DRAP Price Delays Leave 40 Drugs Unavailable: Pharma Stocks in Focus
Forty medicines have gone missing from Pakistani pharmacies because the drug regulator has not cleared new prices for them, a bottleneck that squeezes listed pharma makers even as it hurts patients.